Supplement to "The risk of myocardial infarction, stroke and revascularization among patients with psoriasis treated with apremilast compared to biologics and DMARDs: a cohort study in the United States MarketScan database"

Published: 19-03-2020| Version 1 | DOI: 10.17632/h7bf4p8p98.1
Contributor:
Rebecca Persson

Description

Detailed Methods and Supplementary Tables for the Research Letter published in the Journal of the American Academy of Dermatology: The risk of myocardial infarction, stroke and revascularization among patients with psoriasis treated with apremilast compared to biologics and DMARDs: a cohort study in the United States MarketScan database

Files